Urol. praxi, 2015; 16(2): 75-79

How to proceed in prenatal ultrasonographic detection of urinary tract dilatation

MUDr.Ivo Novák, Ph.D.1, doc.MUDr.Sylva Skálová, Ph.D.2, MUDr.Karel Hodík, Ph.D.3, MUDr.Pavel Rejtar, Ph.D.4
1 Urologická klinika FN a LF UK, Hradec Králové
2 Dětská klinika FN a LF UK, Hradec Králové
3 Porodnická a gynekologická klinika FN a LF UK Hradec králové
4 Radiologická klinika FN a LF UK Hradec Králové

Routine prenatal screening of pregnant women increases the numbers of organ abnormalities found. Repeat ultrasonographic examination is the

most important prenatal diagnostic method in the uropoietic system. Urinary tract dilatation is the most common ultrasonographic finding. The

aetiology is varied. Postnatally, in addition to ultrasonographic evaluation to confirm or rule out the prenatal finding, other tests are performed

in order to refine the diagnosis (voiding cystourethrography, static / dynamic renal scintigraphy, urethrocystoscopy, lower urinary tract urodynamic

testing). For the patient, it is of major importance to determine the effect of the congenital defect on renal function, while considering

the diagnostic benefit of the methods of examination depending on their invasiveness and the associated radiation burden. Postnatally, the

individual tests must be performed in a time sequence with respect to the presumed severity of the defect. The outcome should be a decision

to indicate early treatment to protect renal function. Multidisciplinary collaboration is required for optimal diagnostic and therapeutic efficacy.

Keywords: ultrasonography examination, urinary dilatation, prenatal and postnatal diagnosis

Published: May 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Novák I, Skálová S, Hodík K, Rejtar P. How to proceed in prenatal ultrasonographic detection of urinary tract dilatation. Urol. praxi. 2015;16(2):75-79.
Download citation

References

  1. Beke A, Eros FR, Pete B, Szabo I, Gorbe E, Rigo J Jr. Efficacy of prenatal ultrasonography in diagnosis urogenital developmental anomalies in newborns BMC Pregnancy Childbirth. 2014; 14: 82. Go to original source... Go to PubMed...
  2. Gearhart JP, Rink RC, Mouriquand PDE. Pediatric Urology. 1st edition, Philadelphia, W.B. Saunders Company; 2001: 1083.
  3. van Vuuren SH, Damen-Elias HA, Stigter RH, van der Doef R, Goldschmeding R, de Jong TP, Westers P, G.H. Visser, Pistorius L. Size and volume charts of fetal kidney, renal pelvis and adrenal gland. Ultrasound Obstet Gynecol. 2012; 40(6): 659-664. Go to original source... Go to PubMed...
  4. Zerhau P, Gerychová R, Husár M. Prenatální perforace močového měchýře s ascitem plodu řešená peritoneoamniální drenáží (abstrakt). Ces urol 2007; 11(1): 28.
  5. Adiego B, Martinez-Ten P, Perez-Pedregosa J, Illescas T, Barron E, Wong AE, Sepulveda W. Antenatally diagnosed renal duplex anomalies: sonographic features and long-term postnatal outcome. J Ultrasound Med. 2011; 30(6): 809-815. Go to original source... Go to PubMed...
  6. Becker AM. Postnatal evaluation od infants with an abnormal antenatal renal sonogram. Current Opinion in Pediatrics 2009; 21: 207-213. Go to original source... Go to PubMed...
  7. Shipp TD, Nguyen HT, Bromley B, Lyons JG, Benacerraf BR. Importance of renal abnormalities first identified in the third trimester after normal findings on a detailed second-trimester structural fetal survey. J Ultrasound Med. 2011; 30(11): 1567-1572. Go to original source... Go to PubMed...
  8. Wang Y, Cai A, Sun J, Li T, Wang B, Li J. Prenatal diagnosis of penoscrotal transposition with 2- and 3-dimensional ultrasonography. J Ultrasound Med. 2011; 30(10): 1397-1401. Go to original source... Go to PubMed...
  9. Davenport MT, Merguerian PA, Koyle M. Antenatally diagnosed hydronephrosis: current postnatal management. Pediatr Surg Int. 2013; 29: 207-214. Go to original source... Go to PubMed...
  10. Grignon A, Filion A, Filiatrault D, et.al. Urinary tract dilatation in utero: classification and clinical applications. Radiology 1986; 160: 645-647. Go to original source... Go to PubMed...
  11. Nguen TT, A Herndon CD, Cooper Ch, Gatti J, Kirsch A, Kokorowski P, Lee R, Brayfield MP, Metcalfe P, Yerkes E, Cendron M, Campbell JB. The Society for Fetal Urology consensus statement on the evaluation and nanamegent of antenatal hydronefrosis. Journal of Pediatric Urology 2010; 6: 212-231. Go to original source... Go to PubMed...
  12. Taor K, Krishnan V, Sharbidre KG, Andhare A, Kulkarni BR, Bopche S, Patil V. Prenatal sonographic diagnosis of fetal persistent urogenital sinus with congenital hydrocolpos. Ultrasound Obstet Gynecol. 2010; 36(5): 641-643. Go to original source... Go to PubMed...
  13. Yamaçake KGR, Nguyen HT. Current management of antenatal hydronephrosis. Pediatr Nephrol. 2013; 28: 237-243. Go to original source... Go to PubMed...
  14. Emmanuelli V, Lahoche-Manucci A, Holder-Espinasse M, Devisme L, Vaast P, Dieux-Coeslier A, Dehennault M, Petit S, Besson R, Houfflin-Debarge V. Prenatal diagnosis of hyperechogenic kidneys: A study of 17 cases. J Gynecol Obstet Biol Reprod. (Paris). 2010; 39(8): 637-646. Go to original source... Go to PubMed...
  15. Amsalem H, Fitzgerald B, Keating S, Ryan G, Keunen J, Pippi Salle JL, Berger H, Aiello H, Ota?o L, Bernier F, Chitayat D. Congenital megalourethra: prenatal diagnosis and postnatal/autopsy findings in 10 cases. Ultrasound Obstet Gynecol. 2011; 37(6): 678-683. Go to original source... Go to PubMed...
  16. Morris RK, Ruano R, Kilby MD. Effectiveness of fetal cystoscopy as a diagnostic and therapeutic intervention for lower urinary tract obstruction: a systematic review. Ultrasound Obstet Gynecol. 2011; 37(6): 629-637. Go to original source... Go to PubMed...
  17. Gatti JM, Broecker BH, Scherz HC, Perez-Brayfield MR, Kirsch AJ. Antenatal hydronephrosis with postnatal resolution: how long are postnatal studies warranted? Urology 2001; 57: 1178. Go to original source... Go to PubMed...
  18. Šmakal O. Diagnostika a léčba vrozených vad zdvojené ledviny u dětí. Urol. Praxi, 2010; 11(6): 216-318.
  19. Mihál V, Michálková K, Flögelová H, Šmakal O. Bilaterální intravezikální ureterokély u novorozence jako příčina oboustranné dilatace kalichopánvičkového systému ledvin. Pediatr. pro Praxi, 2008; 9(3): 202-203.
  20. Kitchens, David M, Herndon, CD Anthony. Antenatal hydronephrosis. Current urology reports, 2009; 10(2): 126-133. Go to original source... Go to PubMed...
  21. Vižďa J, Lepej J, Křížová H, Urbanová E. Atlas scintigrafie ledvin. Prvé vydání, Praha, Agentura Pankrác spol. s.r.o.; 2002: 72.
  22. Carr MC. Neuropathic bladder in the neonate. Clin Perinatol. 2014; 41(3): 725-733. Go to original source... Go to PubMed...
  23. Sedláček J, Kočvara R, Langer J, Dítě Z, Dvořáček J, Jiskrová H. Výsledky léčby neonatální hydronefrózy. Čes-slov Pediat. 2008; 63(12): 653-659.
  24. Shamshirsaz AA, Ravangard SF, Egan JF, Prabulos AM, Shamshirsaz AA, Ferrer FA, Makari JH, Leftwich HK, Herbst KW, Billstrom RA, Sadowski A, Gurram P, Campbell WA. Fetal hydronephrosis as a predictor of neonatal urologic outcomes. J Ultrasound Med. 2012; 31(6): 947-954. Go to original source... Go to PubMed...
  25. Tekgül S, Riedmiller H, Hoebeke P, Kočvara R, Rien JM, Nijman, Radmayr CH, Stein R, Dogan HS. EAU Guidelines on Vesicoureteral Reflux in Children. European Urology, 2012; 62: 534-542. Go to original source... Go to PubMed...
  26. Braga LH, Mijovic H, Farrokhyar F, Pemberton J, deMaria J, Lorenzo AJ. Antibiotic Prophylaxis for Urinary Tract Infections in Antenatal Hydronephrosis. Pediatrics 2013;131; 251-261. Go to original source... Go to PubMed...
  27. Šmakal O, Šarapatka J, Flögelová H, Bakaj L, Zbrožková L. Je vhodné podávat atb profylaxi kojencům se závažnou hydronefrózou před provedením pyeloplastiky? Ces. Urol. 2013; 17(3): 193-198.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.